← Back to Search

Neurostimulation

Dorsal Root Ganglion Stimulation for Knee Arthritis

N/A

Recruiting

Research Sponsored by Kenneth B Chapman

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Primary complaint of chronic knee pain for at least 1 year that interferes with functional activities

Age >= 21 years old

Timeline

Screening 3 weeks

Treatment Varies

Follow Up 1-, 3-, 6-, 9-, and 12 months post-implant

Awards & highlights

Study Summary

This trial will test if a new pain treatment, dorsal root ganglion stimulation (DRG-S), can effectively treat arthritic pain of the knee.

Who is the study for?

This trial is for adults over 21 with chronic knee pain due to arthritis, who have tried other treatments like physical therapy and medications without relief. It's for those not suitable or willing to undergo knee surgery, including patients with a history of surgical repair. Participants must have moderate to severe arthritis confirmed by recent scans and significant pain despite past interventions.Check my eligibility

What is being tested?

The study tests if Dorsal Root Ganglion Stimulation (DRG-S) can effectively relieve arthritic knee pain. DRG-S targets specific nerves affected by tissue damage or dysfunction from conditions like trauma or osteoarthritis, aiming to reduce mechanical pain in the knee.See study design

What are the potential side effects?

While the trial description does not list specific side effects, similar procedures may cause discomfort at the stimulation site, infection risk, nerve damage potential, and possible changes in pain sensation.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below

Select...

I have had knee pain for over a year that affects my daily activities.

Select...

I am 21 years old or older.

Select...

My current pain level is high, at or above a 6 out of 10.

Select...

I have tried and not benefited from certain knee pain treatments or surgery.

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ 1-, 3-, 6-, 9-, and 12 months post-implant

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~1-, 3-, 6-, 9-, and 12 months post-implant

This trial's timeline: 3 weeks for screening, Varies for treatment, and 1-, 3-, 6-, 9-, and 12 months post-implant for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.

Primary outcome measures

Treatment success rate at 3 months

Secondary outcome measures

European Quality of Life 5 Dimension (EQ-5D)

Kellgren-Lawrence System for Classification of Osteoarthritis

Knee Range of Motion (ROM)

+9 more

Other outcome measures

Incidence of Treatment-Emergent Adverse Events [Safety and Tolerability]

Trial Design

2Treatment groups

Experimental Treatment

Group I: Surgically Repaired Knee OsteoarthritisExperimental Treatment1 Intervention

DRG-S for knee osteoarthritis patients with history of surgical repair of the knee

Group II: Non-operated Knee OsteoarthritisExperimental Treatment1 Intervention

DRG-S for knee osteoarthritis patients with no history of knee surgery

0 / 4Eligibility criteria met

Find a Location

Who is running the clinical trial?

Kenneth B ChapmanLead Sponsor

AbbottIndustry Sponsor

751 Previous Clinical Trials

478,145 Total Patients Enrolled

Media Library

Dorsal Root Ganglion Stimulation (Neurostimulation) Clinical Trial Eligibility Overview. Trial Name: NCT05103527 — N/A

Chronic Knee Pain Research Study Groups: Non-operated Knee Osteoarthritis, Surgically Repaired Knee Osteoarthritis

Chronic Knee Pain Clinical Trial 2023: Dorsal Root Ganglion Stimulation Highlights & Side Effects. Trial Name: NCT05103527 — N/A

Dorsal Root Ganglion Stimulation (Neurostimulation) 2023 Treatment Timeline for Medical Study. Trial Name: NCT05103527 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Are subjects being accepted for this trial at present?

"Affirmative. Based on the data from clinicaltrials.gov, this medical study is still enrolling participants since it was first posted in January 1st 2022 and last updated April 29th 2022. The trial requires 30 volunteers to be recruited at one specified site."

Answered by AI

What is the scope of participants for this experiment?

"Absolutely! Details hosted on clinicaltrials.gov validate that the trial is in progress, with an origin date of January 1st 2022 and a recent update from April 29th 2022. The research project has a goal of enlisting 30 participants at one centre."

Answered by AI